Mosquida, Rosalina .
HRN: 28-56-36 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/13/2026
CEFTRIAXONE 1G (VIAL)
02/13/2026
02/19/2026
IV
2G
OD
CAP MR
Pending Pharmacy Acceptance
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: